Impact of non-compliance on the therapeutic coverage of oxybutynin – comparison of once- and twice-daily oral formulations.

D. Hughes, D.A. Hughes

    Research output: Book/ReportCommissioned report

    Original languageEnglish
    PublisherUnknown
    Commissioning bodyJanssen Pharmaceutica
    Edition2002
    Publication statusPublished - 1 Jan 2002

    Cite this